| $385M | ||
| $350M | ||
| $215M | ||
| $82M | ||
| $76M | ||
| $62M |
Buys | $634,789 | 19 | 100 |
Sells | $0 | 0 | 0 |
| Smith Stan | director | 8 | $301,620 | 0 | $0 | $301,620 |
| Vitoc Vlad | Chief Executive Officer | 5 | $101,540 | 0 | $0 | $101,540 |
| Louie Ngar Yee | director | 1 | $100,000 | 0 | $0 | $100,000 |
| Luput Cristian | director | 3 | $51,631 | 0 | $0 | $51,631 |
| CHAOUKI STEVEN M | director | 1 | $49,999 | 0 | $0 | $49,999 |
| Guerrero Ramiro | director | 1 | $30,000 | 0 | $0 | $30,000 |
MAIA Biotechnology, Inc., a clinical stage biotechnology company, engages in the discovery, development, and commercialization of therapies targeting cancer, primarily non-small cell lung cancer. Its lead asset, THIO, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. The company was founded in 2018 and is headquartered in Chicago, Illinois.
Over the last 12 months, insiders at MAIA Biotechnology, Inc. have bought $634,789 and sold $0 worth of MAIA Biotechnology, Inc. stock.
On average, over the past 5 years, insiders at MAIA Biotechnology, Inc. have bought $1.57M and sold $0 worth of stock each year.
Highest buying activity among insiders over the last 12 months: Smith Stan (director) — $301,620. Vitoc Vlad (Chief Executive Officer) — $101,540. Louie Ngar Yee (director) — $100,000.
The last purchase of 57,189 shares for transaction amount of $69,999 was made by Smith Stan (director) on 2025‑12‑22.
| 2025-12-22 | Smith Stan | director | 57,189 0.1421% | $1.22 | $69,999 | +45.68% | ||
| 2025-12-22 | Louie Ngar Yee | director | 81,699 0.203% | $1.22 | $100,000 | +45.68% | ||
| 2025-12-22 | CHAOUKI STEVEN M | director | 40,849 0.1015% | $1.22 | $49,999 | +45.68% | ||
| 2025-12-05 | Smith Stan | director | 13,740 0.0375% | $1.20 | $16,441 | +38.33% | ||
| 2025-11-28 | Vitoc Vlad | Chief Executive Officer | 50,000 0.1301% | $1.14 | $56,830 | +38.56% | ||
| 2025-11-28 | Luput Cristian | director | 18,145 0.0463% | $1.11 | $20,230 | +38.56% | ||
| 2025-11-26 | Smith Stan | director | 15,000 0.0384% | $1.04 | $15,582 | +53.77% | ||
| 2025-11-26 | Vitoc Vlad | Chief Executive Officer | 22,000 0.0568% | $1.05 | $23,019 | +53.77% | ||
| 2025-11-26 | Luput Cristian | director | 20,000 0.0533% | $1.08 | $21,616 | +53.77% | ||
| 2025-11-25 | Smith Stan | director | 15,000 0.0435% | $0.98 | $14,700 | +68.06% | ||
| 2025-11-25 | Vitoc Vlad | Chief Executive Officer | 10,500 0.0301% | $0.97 | $10,144 | +68.06% | ||
| 2025-11-25 | Luput Cristian | director | 10,000 0.029% | $0.98 | $9,785 | +68.06% | ||
| 2025-11-24 | Smith Stan | director | 10,000 0.0293% | $0.99 | $9,900 | +64.81% | ||
| 2025-11-24 | Vitoc Vlad | Chief Executive Officer | 10,000 0.0293% | $0.99 | $9,891 | +64.81% | ||
| 2025-11-21 | Vitoc Vlad | Chief Executive Officer | 1,800 0.0049% | $0.92 | $1,656 | +77.18% | ||
| 2025-10-01 | Smith Stan | director | 19,230 0.0492% | $1.30 | $24,999 | -9.64% | ||
| 2025-06-03 | Smith Stan | director | 33,333 0.0943% | $1.50 | $50,000 | -9.71% | ||
| 2025-05-08 | Smith Stan | director | 66,666 0.1724% | $1.50 | $99,999 | -17.86% | ||
| 2025-05-08 | Guerrero Ramiro | director | 20,000 0.0517% | $1.50 | $30,000 | -17.86% | ||
| 2025-03-03 | Smith Stan | director | 25,000 0.0841% | $1.50 | $37,500 | -4.12% |
| Smith Stan | director | 1421478 3.8385% | $2.19M | 52 | 0 | <0.0001% |
| Louie Ngar Yee | director | 1248888 3.3724% | $1.92M | 5 | 0 | +6.58% |
| Vitoc Vlad | Chief Executive Officer | 903421 2.4395% | $1.39M | 26 | 0 | <0.0001% |
| Guerrero Ramiro | director | 588218 1.5884% | $905,855.72 | 20 | 0 | <0.0001% |
| Luput Cristian | director | 437628 1.1817% | $673,947.12 | 21 | 0 | <0.0001% |
| CHAOUKI STEVEN M | director | 151873 0.4101% | $233,884.42 | 4 | 0 | +3.42% |
| Vlad Laurentiu | 376933 1.0178% | $580,476.82 | 1 | 0 | <0.0001% | |
| Obrocea Mihail | Chief Medical Officer | 27100 0.0732% | $41,734.00 | 1 | 0 | <0.0001% |
| Gryaznov Sergei | Chief Scientific Officer | 24511 0.0662% | $37,746.94 | 1 | 0 | <0.0001% |
| MCGUIRE JOSEPH F | Chief Financial Officer | 9400 0.0254% | $14,476.00 | 2 | 0 | <0.0001% |
MAIA Biotechnology, Inc. (MAIA) | $5,354,267 | 110 | -35.34% | $57.03M |
$1,695,621 | 55 | 17.90% | $59.7M | |
$103,288,323 | 51 | 4.78% | $50.39M | |
$693,326 | 47 | -16.18% | $48.34M | |
$24,478,755 | 37 | -34.59% | $49.82M | |
$27,151,286 | 27 | -16.85% | $63.56M | |
$226,127 | 22 | -27.62% | $54.43M | |
$1,602,584 | 20 | 15.26% | $66.84M | |
$3,763,566 | 15 | -21.70% | $61.11M | |
$277,862 | 15 | 59.79% | $57.32M | |
$39,336,371 | 14 | -17.87% | $57.61M | |
$19,300,035 | 11 | 45.88% | $50.82M | |
$32,684,649 | 8 | -15.84% | $69.98M | |
$45,000,000 | 6 | -31.22% | $60.16M | |
$762,555 | 4 | -34.52% | $67.32M | |
$657,791 | 4 | -52.05% | $48.99M | |
$67,369,250 | 3 | -22.09% | $48.91M | |
$12,498 | 2 | 39.61% | $48.77M | |
$4,030 | 1 | 9.14% | $53.08M |
| Increased Positions | 17 | +130.77% | 257,493 | +10.85% |
| Decreased Positions | 2 | -15.38% | 114,493 | -4.82% |
| New Positions | 9 | New | 162,183 | New |
| Sold Out Positions | 2 | Sold Out | 114,493 | Sold Out |
| Total Postitions | 28 | +115.38% | 3M | +6.02% |
| Vanguard Group Inc | $1,765.00 | 2.98% | 1.1M | -37,624 | -3.3% | 2025-09-30 |
| Centric Wealth Management | $920.00 | 1.55% | 574,898 | +1,500 | +0.26% | 2025-09-30 |
| Geode Capital Management, Llc | $434.00 | 0.73% | 271,056 | +48,873 | +22% | 2025-09-30 |
| Marshall Wace, Llp | $177.00 | 0.3% | 110,467 | +94,302 | +583.37% | 2025-09-30 |
| Blackrock, Inc. | $168.00 | 0.28% | 104,857 | +1,592 | +1.54% | 2025-09-30 |
| State Street Corp | $121.00 | 0.2% | 75,550 | 0 | 0% | 2025-09-30 |
| Northern Trust Corp | $62.00 | 0.11% | 39,032 | 0 | 0% | 2025-09-30 |
| Bridgeway Capital Management, Llc | $58.00 | 0.1% | 36,000 | 0 | 0% | 2025-09-30 |
| Centerpoint Advisory Group | $25.00 | 0.04% | 15,730 | 0 | 0% | 2025-09-30 |
| Wealth Enhancement Advisory Services, Llc | $24.00 | 0.04% | 14,800 | 0 | 0% | 2025-09-30 |